ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results
-
Israel court extends detention of two Gaza flotilla activists
-
Massive search continues for two missing US soldiers in Morocco
-
Players keep up battle with tennis majors as they decry Roland Garros prize money
-
Pistons rout Magic to complete comeback, advance in NBA playoffs
-
Trump says US and Iran in 'positive' talks, unveils plan to escort Hormuz ships
-
Talisman Endrick fires resurgent Lyon into third in France
-
Verstappen laments spin and struggle for pace in Miami
-
Teen Antonelli wins again in Miami to extend title race lead
-
Ferrari's Leclerc admits he threw away Miami podium finish
-
Cristian Chivu, a winner with Inter on the pitch and in the dugout
-
Key players from Inter Milan's Serie A title triumph
-
No.4 Young cruises to PGA title at Doral
-
Vinicius double delays Barca title as Real Madrid down Espanyol
-
Inter Milan win Italian title for third time in six seasons
-
Spurs solved mental frailty to boost survival bid: De Zerbi
-
Miami champ Antonelli shrugs off success, vows 'back to work'
-
Man Utd beat Liverpool, Spurs climb out of relegation zone
-
Spurs out of relegation zone after vital win at Villa
-
No.1 Korda cruises to LPGA Mexico crown
-
Thompson-Herah shines at world relays, Tebogo helps Botswana to win
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Germany's Merz says not 'giving up on working with Donald Trump'
-
Mercedes' Kimi Antonelli wins Miami Grand Prix
-
Man Utd job feels 'natural' to Carrick
-
Ferguson taken to hospital before Man Utd win against Liverpool
-
'Devil Wears Prada 2' takes top spot in N. America box office
-
Iran weighs US response to peace plan after warning against military action
-
Gladbach sink Dortmund, St Pauli edge closer to drop
-
Rubio to visit Rome, meet Pope Leo after Trump row
-
Kyiv hits Russian oil sites as eight killed in both countries
-
Iran says US military operation 'impossible' as Trump mulls peace proposal
-
Man Utd beat Liverpool to secure Champions League place
-
Two die in 'respiratory illness' outbreak on Atlantic cruise ship
-
Barcelona sink Bayern to reach women's Champions League final
-
True Love lands eighth English 1000 Guineas for O'Brien
-
Sinner dismantles Zverev to win Madrid Open, set record
-
Brilliant Bordeaux clean out Bath to reach Champions Cup final
-
Second unexploded shell found at illegal French rave: minister
-
Bournemouth eye European place after crushing Palace
-
Pogacar ends dominant Tour of Romandie with fourth win
-
Chakravarthy, Narine help Kolkata stay alive in IPL
-
Daughter says Maradona died after carers' plan 'went out of control'
-
Two women suffocate on migrant boat seeking to reach UK
-
How Schalke returned to the Bundesliga after their 'worst season ever'
-
Two women die on migrant boat seeking to reach UK
-
Mumbai coach Jayawardene backs Suryakumar to find his 'rhythm'
-
Under full moon, Shakira thrills 2 million fans on Rio's Copacabana beach
-
Bangkok food vendor curbs push city staple from the streets
-
More Nepalis drive electric, evading global fuel shocks
-
Latecomer Japan eyes slice of rising global defence spending
ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results
NORTHVALE, NJ / ACCESS Newswire / February 13, 2026 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its third fiscal quarter ended December 31, 2025 of Fiscal Year 2026.
The upward trend in revenues, as reported in the Company's previous quarterly reports, continues for this third fiscal quarter of fiscal year ended March 31, 2026. For the nine months ended December 31, 2025 revenues increased 9% and 7% for the three months ended December 31, 2025, as compared to the same periods last fiscal year. Research and development activity and expense are continuing on the Company's proprietary non-invasive musculoskeletal pain therapy medical device. When engineering development is completed, the Company intends to submit a 510(k) Pre-Market Notification to the FDA for clearance to market.
Revenues for the three months ended December 31, 2025 were $803,088 as compared to $749,510 for the three months ended December 31, 2025, an increase of 8%. Loss from operations for the three months ended December 31, 2025 was $84,441 as compared to loss of $89,269 for the same period last year.
Revenues for the nine months ended December 31, 2025 were $2,664,2611 as compared to $2,447,391 for the nine months ended December 31, 2024, an increase of 9%. Income from operations for the nine months ended December 31, 2025 was $27,346 as compared to income of $29,154 for the same period last year.
Complete financial results are available in the Company's Quarterly Report on Form 10Q for December 31, 2025, available at www.sec.gov.
Financial Highlights
Three Months Ended | Nine Months Ended | |||||||||||
December 31, | December 31, | |||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||
Net Revenues | $ | 803,088 | $ | 749,510 | $ | 2,664,261 | $ | 2,447,391 | ||||
Cost of Sales | $ | 530,592 | $ | 481,331 | $ | 1,534,675 | $ | 1,239,527 | ||||
Gross Profit | $ | 272,496 | $ | 268,179 | $ | 1,129,586 | $ | 1,207,864 | ||||
Total Operating Expenses | $ | 356,937 | $ | 357,448 | $ | 1,102,240 | $ | 1,178,710 | ||||
Income (loss) from operations | $ | (84,441 | ) | $ | (89,269 | ) | $ | 27,346 | $ | 29,154 | ||
Total other income (expense) | $ | (30,415 | ) | $ | (142,500 | ) | $ | 72,260 | $ | (45,850 | ) | |
Income (loss) before provision for income taxes | $ | (114,856 | ) | $ | (237,177 | ) | $ | 99,606 | $ | (16,696 | ) | |
Total provision (benefit) for income taxes | - | $ | 500 | $ | 1,500 | $ | 1,500 | |||||
Net income (loss) | $ | (114,856 | ) | $ | (237,677 | ) | $ | 98,106 | $ | (18,196 | ) | |
Basic and diluted per common share | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
Weighted average shares of common stock outstanding - basic and diluted | 67,588,492 | 67,588,492 | 67,588,492 | 67,588,492 | ||||||||
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations. The Company's headquarters, laboratories, FDA-Registered and ISO-13485 Certified medical device and manufacturing operations are located in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for the research, development and commercialization of diversified technologies. Additional information is available at admtronics.com
Sign up for ADMT Investor News Updates emails by filling in the form at the bottom of the page at this link: https://admtronics.com/investor-relations/
Except for historical information contained herein, the matters set forth in this news release are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact Information:
Andre DiMino
+12017676040
[email protected]
SOURCE: ADM Tronics Unlimited Inc.
View the original press release on ACCESS Newswire
O.M.Souza--AMWN
